Market closedNon-fractional

Kamada/KMDA

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Kamada

Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, Proprietary Products segment and Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.

Ticker

KMDA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology

Headquarters

Rehovot, Israel

Employees

378

Kamada Metrics

BasicAdvanced
$1.1B
Market cap
24.08
P/E ratio
$0.21
EPS
0.24
Beta
-
Dividend rate
$1.1B
0.24
4.245
1.976
2.952
3.548
5.90%
24.075
1.801
4.84
11.05
349.389
13.33%
-515.35%
6.20%
-12.64%

What the Analysts think about Kamada

Analyst Ratings

Majority rating from 1 analysts.
Buy

Kamada Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
6.10% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$38M
3.57%
Net income
$2.3M
-54.00%
Profit margin
6.10%
-55.57%

Kamada Earnings Performance

Earnings per share (EPS)

Company profitability
Missed by 33.33%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.04
$0.06
$0.09
$0.04
-
Expected
$0.02
$0.03
$0.05
$0.06
$0.06
Surprise
100.00%
100.00%
80.00%
-33.33%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Kamada stock?

Kamada (KMDA) has a market cap of $1.1B as of July 05, 2024.

What is the P/E ratio for Kamada stock?

The price to earnings (P/E) ratio for Kamada (KMDA) stock is 24.08 as of July 05, 2024.

Does Kamada stock pay dividends?

No, Kamada (KMDA) stock does not pay dividends to its shareholders as of July 05, 2024.

When is the next Kamada dividend payment date?

Kamada (KMDA) stock does not pay dividends to its shareholders.

What is the beta indicator for Kamada?

Kamada (KMDA) has a beta rating of 0.24. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.

Buy or sell Kamada stock

Buy or sell Kamada stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing